How is a voiding trial performed in a patient who has been catheterized?

How to Perform a Voiding Trial After Catheterization

Remove the catheter after backfilling the bladder with 300 mL of warm normal saline, then have the patient void immediately—if they void ≥200 mL, the trial is successful without needing to check post-void residual (PVR); if they void <100 mL, the trial has failed and recatheterization is needed; only measure PVR for intermediate volumes (100-199 mL). This active/backfill method is superior to passive techniques and reduces time to decision while lowering urinary tract infection rates 1, 2, 3.

The Backfill (Active) Voiding Trial Protocol

Step 1: Bladder Preparation

• Instill 300-500 mL of warm normal saline through the existing catheter before removal 2, 4
• This backfill technique provides immediate bladder fullness and eliminates the 3-4 hour wait required for spontaneous filling
• The warm saline is better tolerated and triggers the urge to void more reliably

Step 2: Catheter Removal and Immediate Voiding

• Remove the catheter immediately after instillation
• Prompt the patient to void within 15-30 minutes of catheter removal 1, 2
• The backfill method reduces time to voiding decision by approximately 112 minutes compared to passive methods 4

Step 3: Outcome Determination Using the Voided Volume Algorithm

This is the critical decision point that eliminates unnecessary PVR measurements in 85% of patients 1:

• Voided ≥200 mL: Trial is successful—discharge without catheter, no PVR needed (97% positive predictive value)
• Voided 100-199 mL: Indeterminate—measure PVR by bladder scan or catheterization
  • If PVR allows voided volume to be ≥2/3 of total bladder volume, trial passes
  • If not, discharge with catheter
• Voided <100 mL: Trial has failed—recatheterize (97% negative predictive value)

Why Active/Backfill is Superior to Passive Methods

The evidence strongly favors active voiding trials 2, 3:

• Better correlation with successful voiding (κ = 0.91 vs 0.56 for passive methods) 2
• 63% reduction in urinary tract infections (4.8% vs 12.9%) 3
• Faster decision-making without delaying hospital discharge 4, 3
• 1.56 times more likely to achieve catheter-free state 4

While passive trials (spontaneous bladder filling) may result in fewer patients discharged with catheters in some surgical populations 5, the active method provides more reliable, immediate assessment and significantly reduces infection risk—a critical morbidity outcome 3.

Timing Considerations

• Perform the trial within 3 days of catheterization in most cases 6
• Earlier trials (day 3 vs day 14) are being studied but current evidence supports removal within the first few days when clinically appropriate 7
• For acute urinary retention specifically, a 3-day catheterization period with alpha-blocker therapy is standard before attempting TWOC (trial without catheter) 8, 6

Critical Pitfalls to Avoid

1. Don't rely on a single PVR measurement for decision-making—the AUA guidelines emphasize that PVR has significant variability and false positives/negatives 9

2. Don't use passive voiding trials as your default—despite being common practice, they delay decisions and increase UTI risk 3

3. Don't measure PVR when voided volume is clearly adequate (≥200 mL) or clearly inadequate (<100 mL)—this wastes time and resources 1

4. Ensure adequate voided volume (at least 150 mL minimum) before measuring PVR to get meaningful results 9

Post-Trial Management

• Patients who fail should be discharged with a catheter and alpha-blocker therapy (if retention was due to prostatic obstruction) 6
• Repeat trial in 3-7 days for failed initial attempts
• Monitor for recurrent retention within the first week (occurs in approximately 2-3% of patients) 3